Company Info
Phone(858) 617-6155
Year Established
1997
Ticker
XNCR
Exchange
NASDAQ
Contacts
Bassil I. Dahiyat, Ph.D.CEO
Nancy Valente, M.D.
CDO
John J. Kuch
CFO
John R. Desjarlais, Ph.D.
CSO
Celia Eckert, J.D.
General Counsel
Jeremy Grunstein, Ph.D.
Senior VP, Business Development
Company Description
Xencor is a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer.
